Fracture Repair Surgery — Cost, Top Hospitals & Success Rates | MyMedicPlus

Fracture repair encompasses the range of surgical and non-surgical interventions used to restore bony alignment, achieve stable fixation, and promote healing of broken bones. Simple undisplaced fractures may be managed conservatively with plaster cast or splinting immobilisation; however, displaced, unstable, intra-articular, or open (compound) fractures typically require surgical intervention to restore anatomy and enable early mobilisation. The primary surgical techniques include: open reduction and internal fixation (ORIF) — direct surgical exposure of the fracture, manipulation into anatomical alignment, and fixation with plates, screws, intramedullary (IM) nails, or wires; closed intramedullary nailing — fluoroscopy-guided insertion of a metal rod down the medullary canal of long bones (femur, tibia, humerus) without opening the fracture site; external fixation — temporary or definitive stabilisation using metal pins inserted into bone above and below the fracture connected by an external frame, used for open fractures, polytrauma, and highly comminuted injuries; and percutaneous screw fixation for minimally displaced intra-articular fractures (scaphoid, femoral neck). Minimally invasive plate osteosynthesis (MIPO) uses small incisions and indirect reduction techniques to slide plates along the bone, minimising periosteal stripping and biological disruption. Modern locking plate technology enables fixation in osteoporotic bone by providing angular stability independent of bone screw interface friction.

Fracture repair is indicated across all skeletal sites and injury types. Long bone fractures requiring surgical fixation include femoral shaft fractures (IM nail), distal femoral fractures (retrograde nail or plate), tibial shaft fractures (IM nail or plate), humeral shaft fractures (IM nail or plate), and both-bone forearm fractures (dual plating). Periarticular and intra-articular fractures requiring ORIF for joint congruity restoration include tibial plateau fractures, distal tibial (pilon) fractures, calcaneal fractures, distal radial fractures (most common adult fracture), acetabular fractures, and ankle fractures (bimalleolar, trimalleolar). Hip fractures in elderly patients — displaced femoral neck fractures (treated with hemiarthroplasty or THA in most >65 year olds) and intertrochanteric fractures (treated with cephalomedullary nailing) — represent the highest surgical volume globally. Open (compound) fractures require emergency debridement, irrigation, and temporary or definitive fixation with thorough assessment of soft-tissue and neurovascular injury. Periprosthetic fractures around existing joint replacements are a growing subspeciality managed with plating or revision arthroplasty. Paediatric fractures follow age-specific management principles, often with elastic intramedullary nails or K-wire fixation.

Surgical fixation is indicated when fractures are: displaced beyond acceptable limits (displacement thresholds depend on skeletal site, patient age, and activity level); intra-articular with joint surface incongruity exceeding 2 mm; associated with neurovascular injury requiring stabilisation to protect repairs; open (compound), requiring emergency debridement and fixation; pathological (through tumour or abnormal bone); in the context of multiple injuries (polytrauma) where early skeletal stabilisation reduces systemic complications; or unstable and likely to displace in a cast. Conservative management is appropriate for most stable, undisplaced fractures and many fractures in elderly patients with high anaesthetic risk where displacement in cast is acceptable. Pre-operative assessment includes plain X-rays in two planes, CT scan for complex intra-articular or pelvic fractures to map fracture anatomy, assessment of neurovascular status, and medical optimisation. Bone health assessment is important in fragility fracture patients — osteoporosis treatment should be initiated peri-operatively. Antibiotic prophylaxis and tetanus immunisation are mandatory for open fractures.

Treatment options are tailored to individual patient needs based on disease severity, comorbidities, patient preference, and clinical guidelines. The treating physician will discuss all available options and recommend an approach based on the complete clinical assessment.

First-line treatment follows established evidence-based protocols with well-documented efficacy and safety profiles. This may involve pharmacological therapy with single or combination agents, procedural intervention using minimally invasive or open techniques, or a combination approach integrating multiple treatment modalities.

Second-line options are considered when primary treatment fails to achieve therapeutic targets or is not tolerated. These include alternative agents within the same drug class, different treatment modalities, or escalation to more intensive therapy at specialist centres.

Emerging treatments available through clinical trials or specialist referral include novel targeted agents, biological therapies, advanced procedural techniques, and gene therapy approaches for selected conditions. Patients are encouraged to discuss eligibility for clinical trials with their specialist. Treatment intensity is regularly reassessed and adjusted based on clinical response, ensuring optimal outcomes while minimising unnecessary exposure to treatment-related risks.

The selection of treatment approach follows a systematic assessment of clinical factors, patient preferences, and risk-benefit considerations. Evidence-based guidelines from professional societies including WHO, NICE, and relevant specialty organisations inform treatment selection and protocol design.

Combination treatment strategies are increasingly favoured where multiple modalities provide synergistic benefit. The sequence and intensity of treatment components are titrated based on patient response at defined assessment intervals. Patients not responding adequately to initial treatment undergo structured reassessment to identify alternative approaches or combination strategies.

Personalised medicine approaches using biomarker profiling and genetic analysis are emerging as tools to predict treatment response and guide individualised treatment selection in eligible patients. Multidisciplinary team review ensures all relevant clinical expertise informs treatment decisions for complex cases.

Surgical fracture fixation enables anatomical reduction, stable mechanical fixation, early mobilisation, and faster return to function compared to prolonged cast immobilisation, particularly for complex or high-energy fractures. Early mobilisation after surgical fixation reduces hospital-acquired complications: pneumonia, DVT, pulmonary embolism, pressure sores, and deconditioning — all especially relevant in elderly hip fracture patients where operative fixation within 48 hours reduces 30-day mortality by 30–40% compared to delayed surgery. Intramedullary nailing of femoral and tibial shaft fractures achieves union in 95–98% of cases with minimal surgical trauma to the fracture site. ORIF of intra-articular fractures restores joint congruity, reducing the risk of post-traumatic arthritis. Modern locking plate systems enable early functional loading in osteoporotic bone. External fixators rapidly stabilise polytrauma patients, enabling damage control orthopaedics before definitive fixation when systemic physiology improves. Physiotherapy commencing within days of surgery restores muscle strength and joint range of motion substantially faster than with cast immobilisation.

Fracture-specific complications of surgical repair include: infection — superficial wound infection (2–5%) and deep infection/osteomyelitis (0.5–2%, higher in open fractures reaching 5–15%); non-union (failure of fracture to heal) in 5–10% of long bone fractures, requiring revision surgery with bone grafting; malunion (healing in suboptimal alignment) affecting post-operative function; implant failure — plate or nail breakage before union occurs in 1–3% of cases; avascular necrosis of fracture fragments deprived of blood supply (particularly femoral head, scaphoid, talus); compartment syndrome — elevated pressure within a fascial compartment threatening tissue viability (medical emergency requiring fasciotomy); nerve injury from the fracture itself or retraction during surgery; DVT in 10–30% of pelvic and lower-limb fractures despite prophylaxis; fat embolism syndrome — systemic release of bone marrow fat following long bone fractures, causing respiratory failure, confusion, and petechiae; and post-traumatic arthritis following intra-articular fractures even after anatomical reduction, increasing long-term arthroplasty requirement.

Structured follow-up is essential to optimise treatment outcomes and ensure early identification of complications or disease recurrence. The follow-up schedule is individuialised based on treatment type, disease characteristics, and patient-specific factors.

Standard follow-up scheduling involves: early post-treatment review at 2-4 weeks to assess initial response and manage any early side effects; monthly assessments for the first 3 months to monitor treatment response and titrate therapy as needed; quarterly review for the remainder of the first year; and annual long-term follow-up for stable patients.

Each follow-up visit includes clinical examination, relevant laboratory testing as indicated by the treatment protocol, imaging studies at defined intervals based on condition-specific guidelines, and assessment of patient-reported outcomes and quality of life.

Patients are provided with clear guidance on symptoms requiring urgent medical review between scheduled appointments, including signs of serious complications or disease progression. Remote consultation options including telephone and video review facilitate access to specialist advice between face-to-face appointments. Long-term surveillance continues indefinitely for chronic conditions, with frequency adjusted based on individual risk profile and clinical response.

Surgical fracture repair costs in India are highly competitive. Hip fracture surgery (IM nailing) costs USD 2,500–5,000; distal radius ORIF USD 1,500–3,500; tibial or femoral IM nailing USD 2,000–4,500; complex tibial plateau ORIF USD 3,000–6,000; acetabular ORIF USD 5,000–10,000 — all inclusive of implants, surgeon, anaesthesia, and hospitalisation. Major orthopaedic trauma centres in India include Safdarjung Hospital (Delhi), Lokmanya Tilak Hospital (Mumbai), and JCI-accredited private hospitals (Apollo, Fortis, Manipal). In Thailand fracture fixation costs USD 4,000–10,000; Turkey USD 3,500–8,000. In the USA, IM nailing of a femoral shaft costs USD 30,000–60,000; hip fracture surgery USD 25,000–50,000; complex ORIF USD 20,000–80,000. UK NHS treats emergency fractures free of charge; private costs are GBP 8,000–25,000. India imports DePuy Synthes, Stryker, Zimmer Biomet, and Meril Life Sciences implants at significantly reduced cost, enabling savings of 75–90% versus US pricing for equivalent hardware.

Alternative treatment approaches are considered when first-line treatment is contraindicated, not tolerated, or fails to achieve therapeutic targets. The range of alternatives depends on the specific condition and patient circumstances.

Conservative management with watchful waiting and close monitoring is appropriate for mild or asymptomatic presentations where the natural history is favourable and intervention risks outweigh expected benefits. Regular surveillance allows timely escalation when clinical criteria for active treatment are met.

Non-pharmacological approaches including physiotherapy, occupational therapy, dietary optimisation, and structured lifestyle modification programmes form the foundation of management for many conditions. These interventions reduce symptom burden, improve functional capacity, and may delay or eliminate the need for pharmacological or procedural treatment.

Alternative pharmacological approaches include agents from different drug classes with different mechanisms of action, dosing strategies, or delivery routes. Clinical trials evaluating novel agents may offer access to emerging therapies not yet in routine clinical practice.

Surgical alternatives range from minimally invasive endoscopic or laparoscopic approaches to open surgery, each appropriate for different clinical scenarios. Complementary and integrative medicine approaches including acupuncture, herbal medicine, and mind-body therapies may provide symptomatic benefit for some patients as adjuncts to conventional care, though evidence quality varies and potential interactions with conventional treatment should be discussed with a qualified practitioner.